Daily FNArena News - Australia

Telix Pharmaceuticals’ March quarter performance beat forecasts with company management lauding the two product PSMA imaging strategy

AI impacts on real estate assets are expected to be multi-functional, both positive efficiency/growth as well as disruptive depending on end user demand

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

After the stand out February reporting season, investors were subjected to a 1970’s style oil price shock which set a risk-off waterfall of selling across most of the market

Ahead of incoming Chair Sarah Court assuming her role on June 1, ASIC’s actions already reflect a fundamental shift in the regulator’s philosophy and approach

In a turbulent market, Sigma Healthcare could prove a defensive alternative driven by Chemist Warehouse’s value offering and the company’s international growth

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

Recent court decisions and actions undertaken by ASIC signal a definitive end to corporate complacency regarding regulatory risk in Australia

Analysts discuss the potential impact of the current oil shock on Australia’s banking sector and of increasing AI adoption